Trial reportAIDS and behavior2026
"Safe Places Like These are Rare": Feasibility of the Speaking Out and Allying Relationships (SOAR) Intervention for HIV-Positive Sexual Minority Men in Eastern Cape, South Africa.
Trial report in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Systematic Review of Barriers and Facilitators to the Uptake and Adherence of Injectable PrEP Among Adolescent Girls and Young Women in Sub-Saharan Africa.AIDS and behavior · 2026Review
- AsymptomaticSouthern African journal of HIV medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
In South Africa, sexual minority men (SMM) with HIV exhibit low rates of antiretroviral treatment (ART) adherence. Self-efficacy in disclosing HIV status is known to mediate ART adherence, as SMM may stop ART to avoid unintentional disclosure to family or partners. To address this, we developed "Speaking Out and Allying Relationships" (SOAR), a five-session intervention to improve HIV coping and disclosure skills. We assessed SOAR feasibility using a pilot randomized controlled trial design. SMM in a relationship with sub-optimal ART adherence were consented and block-randomized into SOAR or attention match control (AMC). Feasibility, behavioral and biomedical assessments were completed at baseline, mid- and post-intervention (Weeks 9, 17). Qualitative interview data were analyzed using a thematic approach; quantitative assessment data were analyzed using inferential statistics. 105 SMM enrolled in SOAR (n = 51) and AMC arms (n = 54). Participants were 19-56 years of age (mean = 31). Study retention at week 17 follow up was 94% for SOAR and 92% for AMC arm participants. Feasibility assessments demonstrated 'Good to High' ratings (100%) for content acceptability, safety, and confidentiality. From baseline to Week 17 follow-up, SOAR participants showed improvements in HIV viral suppression (67% to 77%, ns), Relationship Values (5.9 to 6.6; p < 0.01) and Sex Coping (18.3 to 20.1; p < 0.05). Interview findings revealed increased disclosure decisions and use of coping strategies. SOAR is a feasible intervention, building skills among SMM to manage and strengthen relationships with family and partners for improved treatment engagement.
Indexed as
Identifiers
41129024What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.